<DOC>
	<DOCNO>NCT01602250</DOCNO>
	<brief_summary>The systemic toxicity local anaesthetic may treat use lipid emulsion ( `` lipid rescue '' ) . However , evidence-based proof efficacy treatment . The aim intend protocol study effect emulsion Intralipid® toxicity prodromes volunteer receive either levobupivacaine ropivacaine . After sensitization session lidocaine , subject receive double blind , crossover manner i.v . infusion levobupivacaine ropivacaine follow rapid infusion Intralipid® . The primary outcome time appearance early neurologic sign toxicity . In addition , EEG ECG monitor blood sampling perform order evaluate change pharmacokinetics induced emulsion .</brief_summary>
	<brief_title>Local Anaesthetics Toxicity Intralipid®</brief_title>
	<detailed_description>Regional anaesthesia may induce toxic neurologic cardiac reaction relate inadvertent intravenous injection rapid absorption local anaesthetic . Despite appearance less toxic agent ropivacaine levobupivacaine , problem remain . Recently , new therapeutic call `` lipid rescue '' emerge . This rapid injection lipid emulsion suppose act lipid sink , thus delay release toxic molecule target organ . Animal study well clinical report seem favour treatment . However , evidence-based proof efficacy `` lipid rescue '' . The aim study 1 ) verify efficacy lipid emulsion ( Intralipid® 20 % ) toxicity induce local anaesthetic ropivacaine levobupivacaine 2 ) compare effect emulsion two agent . Sixteen volunteer strictly normal ECG EEG participate study . After sensitization session lidocaine , subject receive levobupivacaine ropivacaine i.v . rate 8 mg/min ( max 120 mg ) follow two minute begin infusion bolus injection Intralipid® 20 % saline 120 mL 1 minute . The infusion local anaesthetic stop immediately appearance early sign toxicity . In addition recognition sign subject ( trained sensitization session ) , anaesthesiologist ask subject symptom . A continuous monitoring EEG ECG perform . Sixteen subject complete study consider necessary achieve power 90 % alpha risk 5 % . A mean time first sign 3.8 ± 1.2 min consider placebo group . A 45 % difference primary outcome consider . The study double blind crossover Latin square ( four treatment , four session , four replication ) . The investigator consider time infusion initiation appearance early sign toxicity primary outcome . The secondary outcome change ECG EEG variables pharmacokinetic parameter observe . For purpose , blood sample 8th hour begin local anaesthetic infusion .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<criteria>Volunteers ASA1 Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Anesthetics , local</keyword>
	<keyword>Toxicity</keyword>
	<keyword>Adverse effect</keyword>
</DOC>